Hong Kong - Tiotropium and olodaterol Inhaler
This is a business opportunity from an overseas buyer. Pitch for the business and explain how your company meets their requirements.
Details
- Opportunity closing date
- 13 October 2025
- Opportunity publication date
- 08 September 2025
- Opportunity type
-
Public Sector
- Industry
- Healthcare services
- Enquiries received
- 0
- Value of contract
- to be confirmed
- Your guide to exporting
Description
You must be able to supply a minimum quantity of 336,000 units of tiotropium bromide and olodaterol hydrochloride inhalers.
Each product must meet the following requirements:
• each delivered dose must contain 2.5 mcg of tiotropium and 2.5 mcg of olodaterol
• an inhalation device must be provided free of charge
• each product must contain no fewer than 60 doses
Packaging must meet these requirements:
• the immediate container and all levels of packaging of the actual sales pack must include an English translation
• the expiration date must be expressed in English and/or Arabic numerals in a clear and comprehensible format
This is a 3-year contract with a possible extension of up to 24 months. The closing date for this opportunity is 13 October 2025 at 12pm (Hong Kong Time).
- Opportunity closing date
- 13 October 2025
- Value of contract
- to be confirmed
- The buyer is happy to talk to
- manufacturers, wholesalers, distributors, agents
The deadline to apply for this opportunity has passed.
Visit the
opportunities page
to find another.